Antithymocyte globulin targets (ATG targets)

The target described represents a broad array of cell surface proteins found on various immune and vascular cells, collectively targeted by antithymocyte globulin (ATG). These antigens include critical T-cell markers (CD2, CD3, CD4, CD8), B-cell and dendritic cell markers (HLA-DR, CD40), and adhesion molecules (CD11a, CD18, CD54) [1, 3]. The primary biological role of these targets involves mediating immune recognition, T-cell activation, and leukocyte extravasation. In the context of disease, these molecules are central to the pathogenesis of acute organ rejection, graft-versus-host disease (GVHD), and the autoimmune destruction of hematopoietic stem cells in aplastic anemia [2, 4]. Therapeutic intervention using polyclonal antibodies against these antigens leads to rapid T-cell depletion and immune modulation. This multi-target approach is highly effective for immunosuppression but carries risks such as cytokine release syndrome and increased susceptibility to opportunistic infections [1, 4]. Sources: [1] Mohty M. Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond. Leukemia. 2007;21(7):1387-1394. [2] Popow I, et al. ATG-induced T cell depletion: mechanisms of action and impact on T-cell subsets. Am J Transplant. 2013;13(11):2788-2798. [3] Gaber AO, et al. Review of antithymocyte globulin (thymoglobulin) mechanism of action and relevance to kidney transplantation. ISRN Nephrol. 2012;2012:210398. [4] StatPearls. Antithymocyte Globulin. https://www.ncbi.nlm.nih.gov/books/NBK538234/

Other names

Lymphocyte-reactive antigensThymocyte antigensT-lymphocyte antigensB-lymphocyte antigensNK cell antigensDendritic cell antigensEndothelial cell antigens

Depletion of circulating T-lymphocytes through complement-dependent cytotoxicity (CDC), antibody-dependent cell-mediated cytotoxicity (ADCC), and induction of apoptosis, alongside the modulation of various cell surface molecules involved in leukocyte adhesion and trafficking [1, 2].